These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23257526)

  • 1. A case of slowly progressive type 1 diabetes with insulin independence maintained for 10 years with α-glucosidase inhibitor monotherapy.
    Munakata Y; Yamada T; Takahashi K; Tsukita S; Takahashi K; Sawada S; Imai J; Ishigaki Y; Oka Y; Katagiri H
    Intern Med; 2012; 51(24):3391-4. PubMed ID: 23257526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review.
    Kobayashi M; Ohara N; Ikeda Y; Nagano O; Takada T; Kodama M; Sone H
    Intern Med; 2018 Dec; 57(24):3581-3587. PubMed ID: 30101912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Normalization of High Glutamic Acid Decarboxylase Autoantibody Titers and Preserved Endogenous Insulin Secretion in a Patient with Diabetes Mellitus: A Case Report and Literature Review.
    Ohara N; Kaneko M; Furukawa T; Koike T; Sone H; Tanaka S; Kaneko K; Kamoi K
    Intern Med; 2016; 55(5):485-9. PubMed ID: 26935368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone might prevent the progression of slowly progressive type 1 diabetes.
    Kawano Y; Irie J; Nakatani H; Yamada S
    Intern Med; 2009; 48(12):1037-9. PubMed ID: 19525594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
    J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 8. Slowly progressive type 1 diabetes treated with metformin for five years after onset.
    Hirata T; Shimada A; Morimoto J; Maruyama T
    Intern Med; 2013; 52(23):2635-7. PubMed ID: 24292754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 1997 Nov; 55 Suppl():261-6. PubMed ID: 9434478
    [No Abstract]   [Full Text] [Related]  

  • 10. New horizons in diabetes therapy--alpha glucosidase inhibitors.
    Jawad F
    J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Pharmacological fibre'--alpha-glucosidase inhibition in the management of diabetes.
    McCulloch DK; Tattersall RB
    Diabet Med; 1984 Sep; 1(3):189-90. PubMed ID: 6100939
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study.
    Tseng YH; Tsan YT; Chan WC; Sheu WH; Chen PC
    Diabetes Care; 2015 Nov; 38(11):2068-74. PubMed ID: 26307605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion.
    Dash S; Crisp S; Hartnell S; Donald S; Davenport K; Simmons D; Evans M
    Diabetes Res Clin Pract; 2012 Mar; 95(3):e49-51. PubMed ID: 22136721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
    Raptis SA; Dimitriadis GD
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S265-87. PubMed ID: 11460577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in prevalence of antibodies to GAD and IA-2 and their titers at diagnosis in children with slowly and rapidly progressive forms of type 1 diabetes.
    Urakami T; Yoshida A; Suzuki J; Saito H; Wada M; Takahashi S; Mugishima H
    Diabetes Res Clin Pract; 2009 Jan; 83(1):89-93. PubMed ID: 19019475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
    Martinka E; Rončáková M; Mišániková M; Davani A
    Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
    Odaka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024
    [No Abstract]   [Full Text] [Related]  

  • 19. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
    Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
    Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S; Turco S; Guarino G; Oliviero B; Rustici A; Torella R
    Ann Ital Med Int; 1999; 14(1):7-14. PubMed ID: 10528419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.